Untitled

Yan, Kin; Smith, Robert L.; Collins, Scott D.

doi:10.1023/a:1009944832192

Cited by 6 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recently, microfabricated miniaturized devices have been recognized as potential platforms for screening XO inhibitors. These devices, consisting of micro-channels/micro-detectors, have facilitated high-throughput detection of analytes using microliter or nanoliter volumes of test samples [18]. Chip assays based on surface plasmon resonance (SPR) [19], forster resonance energy transfer (FRET) [20] and immunolabeling have been applied to elucidate the drug-induced XO inhibition.…”

Section: Introductionmentioning

confidence: 99%

On-chip assay for determining the inhibitory effects and modes of action of drugs against xanthine oxidase

Naoghare¹,

Kwon²,

Song³

2010

Journal of Pharmaceutical and Biomedical Analysis

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

On-chip assay for determining the inhibitory effects and modes of action of drugs against xanthine oxidase

Naoghare¹,

Kwon²,

Song³

2010

Journal of Pharmaceutical and Biomedical Analysis

View full text Add to dashboard Cite

Photonic microinstruments for biomolecular sensing and analysis

Smith¹,

Gonzalez²,

Hsueh³

et al.

LEOS 2001. 14th Annual Meeting of the IEEE Lasers and Electro-Optics Society (Cat. No.01CH37242)

View full text Add to dashboard Cite

High-throughput screening of xanthine oxidase inhibitory properties of drug analogs using photodiode array microchip

Lee

Kim

Song

2010

2010 IEEE International Conference on Nano/Molecular Medicine and Engineering

View full text Add to dashboard Cite

We have developed a high-throughput chip-based assay that uses a photodiode array (PDA) microchip system to explore the inhibitory effects of drug analogs on Xanthine oxidase (XO). Inhibitory effects of dithranol (anthracene derivative), aminoglutethimide (anti-steroid), cyclosporine A (immunosuppressant) and naringenin (flavonoid) on XO were elucidated using the chip-based assay in the presence or absence of a free radical scavenging enzyme (SOD, superoxide dismutase). Drug analogs were assessed for their ability to inhibit XO, which loads to a reduction in the conversion of nitroblue tetrazolium (NBT) to NBT diformazan. The reduction of NBT to NBT formazan in the presence of XO and drug analog can be seen. The PDA microchip system employed in this study consists of an array of red light-emitting diodes (LEDs) focused precisely onto the photodetectors of the PDA chip. The ability of drugs to inhibit XO was assessed based on NBT reduction. Free radicals produced due to the oxidation of xanthine by XO resulted in the reduction of NBT to insoluble NBT formazan. We report a new high-throughput chip-based xanthine assay to explore the XO inhibitory properties of drug analogs, along with their modes of action. The work presented here has important implications with regard to rapid and automated drug discovery screening processes in the pharmaceutical industry.

show abstract

Untitled

Cited by 6 publications

References 5 publications

On-chip assay for determining the inhibitory effects and modes of action of drugs against xanthine oxidase

On-chip assay for determining the inhibitory effects and modes of action of drugs against xanthine oxidase

Photonic microinstruments for biomolecular sensing and analysis

High-throughput screening of xanthine oxidase inhibitory properties of drug analogs using photodiode array microchip

Contact Info

Product

Resources

About